| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
|
Basile, Jan
|
|
2006
|
|
3 |
p. 224-227
|
artikel
|
| 2 |
American Society of Hypertension, Inc.The Future of Hypertension Training and Research in Academic Medicine
|
|
|
2006
|
|
3 |
p. 228-231
|
artikel
|
| 3 |
Analysis of Recent Papers in HypertensionJan Basile, MD, Senior Editor
|
Bloch, Michael J
|
|
2007
|
|
3 |
p. 229-231
|
artikel
|
| 4 |
A Systematic Review of the Effects of Home Blood Pressure Monitoring on Medication Adherence
|
Ogedegbe, Gbenga
|
|
2006
|
|
3 |
p. 174-180
|
artikel
|
| 5 |
Class Effects and Labeling of Antihypertensive Drugs
|
Pickering, Thomas G.
|
|
2006
|
|
3 |
p. 215-220
|
artikel
|
| 6 |
Comparison of Increasing Doses of Olmesartan Medoxomil, Losartan Potassium, and Valsartan in Patients With Essential Hypertension
|
Giles, Thomas D.
|
|
2007
|
|
3 |
p. 187-195
|
artikel
|
| 7 |
Controlled-Release Doxazosin as Combination Therapy in Hypertension: The GATES Study
|
Black, Henry R.
|
|
2006
|
|
3 |
p. 159-168
|
artikel
|
| 8 |
Doxazosin Gastrointestinal Therapeutic System: A Clinical Perspective
|
Mann, Samuel J.
|
|
2006
|
|
3 |
p. 207-208
|
artikel
|
| 9 |
Effects of Valsartan or Amlodipine Alone or in Combination on Plasma Catecholamine Levels at Rest and During Standing in Hypertensive Patients
|
Champlain, Jacques de
|
|
2007
|
|
3 |
p. 168-178
|
artikel
|
| 10 |
Genetics and Hypertension
|
Weder, Alan B.
|
|
2007
|
|
3 |
p. 217-223
|
artikel
|
| 11 |
Hypertension and Kidney Damage
|
Griffin, Karen A.
|
|
2006
|
|
3 |
p. 209-214
|
artikel
|
| 12 |
Long-Term Effects of a Losartan-Compared With an Atenolol-Based Treatment Regimen on Carotid Artery Plaque Development in Hypertensive Patients With Left Ventricular Hypertrophy: ICARUS, a LIFE Substudy
|
Fossum, Eigil
|
|
2006
|
|
3 |
p. 169-173
|
artikel
|
| 13 |
Microalbuminuria: What Is It? Why Is It Important? What Should Be Done About It? An Update
|
Chugh, Atul
|
|
2007
|
|
3 |
p. 196-200
|
artikel
|
| 14 |
Morning Hypertension
|
Pickering, Thomas G.
|
|
2007
|
|
3 |
p. 224-228
|
artikel
|
| 15 |
New Antihypertensive Agents: Will They Work in Blacks?
|
Keith C, Ferdinand
|
|
2007
|
|
3 |
p. 165-167
|
artikel
|
| 16 |
Ophthalmoscopic Findings in Malignant Hypertension
|
Hammond, Stephen
|
|
2006
|
|
3 |
p. 221-223
|
artikel
|
| 17 |
Out-of-Office Blood Pressures—Are They Helpful in Guiding the Treatment of Hypertension Patients?
|
Moser, Marvin
|
|
2006
|
|
3 |
p. 202-206
|
artikel
|
| 18 |
Prevalence and Predictors of Poor Antihypertensive Medication Adherence in an Urban Health Clinic Setting
|
Hyre, Amanda D.
|
|
2007
|
|
3 |
p. 179-186
|
artikel
|
| 19 |
Renal Artery Stenosis and Cardiovascular Risk
|
Shafique, Shahzad
|
|
2007
|
|
3 |
p. 201-208
|
artikel
|
| 20 |
Resistant or Difficult-to-Treat Hypertension
|
Calhoun, David A.
|
|
2006
|
|
3 |
p. 181-186
|
artikel
|
| 21 |
RX: PROFESSIONAL INTEGRITY (prn)
|
|
|
2006
|
|
3 |
p. 232
|
artikel
|
| 22 |
Should You Become a Specialist in Clinical Hypertension?
|
|
|
2007
|
|
3 |
p. 234
|
artikel
|
| 23 |
Systemic Inflammation, Blood Pressure, and Stroke Outcome
|
Napoli, Mario Di
|
|
2006
|
|
3 |
p. 187-194
|
artikel
|
| 24 |
The Isosorbide-Hydralazine Story: Is There a Case for Race-Based Cardiovascular Medicine?
|
Ferdinand, Keith C.
|
|
2006
|
|
3 |
p. 156-158
|
artikel
|
| 25 |
The Metabolic Syndrome and Its Relationship to Hypertensive Target Organ Damage
|
Mulé, Giuseppe
|
|
2006
|
|
3 |
p. 195-201
|
artikel
|
| 26 |
The Nonpharmacologic Treatment of Hypertension: How Effective Is It?An Update
|
Moser, Marvin
|
|
2007
|
|
3 |
p. 209-216
|
artikel
|
Tijdschrift beschrijving